Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADMSC-fib Safety and Efficacy in Patients With Chronic Wounds
2024-518789-29-00Phase 2Completed
- Sponsor
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Start
- Mar 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2 trial of adipose-derived mesenchymal stromal cells + fibrin in Chronic wound, sponsored by Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz. Started Mar 2021; status: completed.
02
Drugs
adipose-derived mesenchymal stromal cells + fibrin
03
Conditions
Chronic wound
Beyond the preview
Go deeper on 2024-518789-29-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518789-29-00.